Replies to post #16402 on Algernon Pharmaceuticals Inc (AGNPF)

[McMagyar]

65% is a nice number.. and when
sucesful in selling other 35% will bring in some excitement .

The cloud then would be the clinical cost and time frame for continuing the CC Clinicals for Chronic Cough?

With AI and the flourishing of new illness..
From Spike Protein wxposure( my opinion)
the capital needs and their possible negative impact on dilution.. should be strongly reviewed for possible sale and redirection .. so many opportunities ..

Exciting times to be in bio Pharma